Lung Cancer Clinical Trials

Showing 3741-3760 of 4,288 trials

A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

NCT01591512

The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.

Small Cell Lung Cancer

Fujirebio Diagnostics, Inc.4 participantsStarted May 2011

Eastpointe, Michigan, United States • Bridgeton, Missouri, United States • Saint Joseph, Missouri, United States +1 more locations

UNKNOWN

Health Outcomes and Costs (HOC) in Lung Cancer (LC)

NCT02363101

The purpose of this study is to evaluate the costs, health-related quality of life and preference values from lung cancer patients assisted in a Brazilian public health care unit.

Lung Cancer

Instituto Nacional de Cancer, Brazil300 participantsStarted Mar 2015

Rio de Janeiro, Rio de Janeiro, Brazil

COMPLETEDNA

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

NCT01209520

The trial investigates the feasibility and efficacy of targeting Non-Small Cell Lung Cancer (NSCLC) "driven" by epigenetic changes. The investigators study the impact of 5-azacitidine (Vidaza®, Celgene, Summit, NJ, USA) in combination with conventional cytotoxic chemotherapy in a sequential fashion. The study population consists of all NSCLC patients who undergo "curative" lung cancer resection and whose tumors harbor hypermethylation in any of the protocol-specific genes (samples will be banked for additional molecular testing including other 21 loci which have shown to be important in lung carcinogenesis.

Lung CancerNon Small Cell Lung CarcinomaHypermethylation

University of Miami6 participantsStarted Jul 2009

Miami, Florida, United States

A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

Health Outcomes and Costs (HOC) in Lung Cancer (LC)

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Related Searches

A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations

A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC

Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer

Lung Cancer Nurse Model: a Phase II Study

Simultaneous CBCT Acquisition During Arc Radiotherapy

Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)

A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)

VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer

Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)

Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma

Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial

A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1)

A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.

A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer.

Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors